| Optically active iridium imidazol-2-ylidene-oxazoline complexes: preparation and use in asymmetric hydrogenation of arylalkenes MC Perry, X Cui, MT Powell, DR Hou, JH Reibenspies, K Burgess Journal of the American Chemical Society 125 (1), 113-123, 2003 | 516 | 2003 |
| Chiral imidazolylidine ligands for asymmetric hydrogenation of aryl alkenes MT Powell, DR Hou, MC Perry, X Cui, K Burgess Journal of the American Chemical Society 123 (36), 8878-8879, 2001 | 319 | 2001 |
| CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells KF Chen, CY Liu, YC Lin, HC Yu, TH Liu, DR Hou, PJ Chen, AL Cheng Oncogene 29 (47), 6257-6266, 2010 | 194 | 2010 |
| New, optically active phosphine oxazoline (JM-Phos) ligands: Syntheses and applications in allylation reactions DR Hou, JH Reibenspies, K Burgess The Journal of Organic Chemistry 66 (1), 206-215, 2001 | 157 | 2001 |
| JM-PHOS ligands: Second-generation phosphine oxazolines for asymmetric catalysis DR Hou, K Burgess Organic Letters 1 (11), 1745-1747, 1999 | 65 | 1999 |
| Cancerous inhibitor of protein phosphatase 2A mediates bortezomib-induced autophagy in hepatocellular carcinoma independent of proteasome HC Yu, DR Hou, CY Liu, CS Lin, CW Shiau, AL Cheng, KF Chen PloS one 8 (2), e55705, 2013 | 52 | 2013 |
| Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A KF Chen, HC Yu, CY Liu, HJ Chen, YC Chen, DR Hou, PJ Chen, ... Molecular cancer therapeutics 10 (5), 892-901, 2011 | 49 | 2011 |
| Electronic effects of ruthenium-catalyzed [3+ 2]-cycloaddition of alkynes and azides DR Hou, TC Kuan, YK Li, R Lee, KW Huang Tetrahedron 66 (48), 9415-9420, 2010 | 47 | 2010 |
| Synthesis of (+)-cladospolide C CY Chou, DR Hou The Journal of Organic Chemistry 71 (26), 9887-9890, 2006 | 43 | 2006 |
| 1, 2, 3-Triazole derivatives as new cannabinoid CB1 receptor antagonists DR Hou, S Alam, TC Kuan, M Ramanathan, TP Lin, MS Hung Bioorganic & medicinal chemistry letters 19 (3), 1022-1025, 2009 | 39 | 2009 |
| Regioselective Palladium-Catalyzed Formate Reduction of N-Heterocyclic Allylic Acetates HY Cheng, CS Sun, DR Hou The Journal of Organic Chemistry 72 (7), 2674-2677, 2007 | 34 | 2007 |
| The nature of cyclopentyne from different precursors JC Gilbert, EG McKinley, DR Hou Tetrahedron 53 (29), 9891-9902, 1997 | 33 | 1997 |
| Characterization of the role of protein–cysteine residues in the binding with sodium arsenite YY Chang, TC Kuo, CH Hsu, DR Hou, YH Kao, RN Huang Archives of toxicology 86, 911-922, 2012 | 32 | 2012 |
| Formation of 4, 5, 6, 7-tetrahydroisoindoles by palladium-catalyzed hydride reduction DR Hou, MS Wang, MW Chung, YD Hsieh, HH Gavin The Journal of Organic Chemistry 72 (24), 9231-9239, 2007 | 32 | 2007 |
| Asymmetric aza-Michael addition: synthesis of (−)-allosedridine and (−)-2-epi-ethylnorlobelol LJ Chen, DR Hou Tetrahedron: Asymmetry 19 (6), 715-720, 2008 | 30 | 2008 |
| Efficient syntheses of oncinotine and neooncinotine DR Hou, HY Cheng, EC Wang The Journal of Organic Chemistry 69 (18), 6094-6099, 2004 | 30 | 2004 |
| Pericyclic reactions of free and complexed cyclopentyne JC Gilbert, DR Hou, JW Grimme The Journal of Organic Chemistry 64 (5), 1529-1534, 1999 | 30 | 1999 |
| Organocatalyzed Enantioselective Michael Addition of 2‐Hydroxypyridines and α, β‐Unsaturated 1, 4‐Dicarbonyl Compounds YC Wu, Y Jhong, HJ Lin, SP Swain, HHG Tsai, DR Hou Advanced Synthesis & Catalysis 361 (21), 4966-4982, 2019 | 29 | 2019 |
| Synthesis of α-C-Galactosylceramide via Diastereoselective Aziridination: The New Immunostimulant 4′-epi-C-Glycoside of KRN7000 YJ Chang, YC Hsuan, ACY Lai, YC Han, DR Hou Organic letters 18 (4), 808-811, 2016 | 28 | 2016 |
| Asymmetric Synthesis of (–)‐Lentiginosine by Double Aza‐Michael Reaction SW Liu, HC Hsu, CH Chang, HHG Tsai, DR Hou European Journal of Organic Chemistry 2010 (25), 4771-4773, 2010 | 27 | 2010 |
